| 000 | 01777 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513002848.0 | ||
| 264 | 0 | _c19800327 | |
| 008 | 198003s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19800115)45:2<280::aid-cncr2820450213>3.0.co;2-o _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEppinger-Helft, M | |
| 245 | 0 | 0 |
_aChemoimmunotherapy with Corynebacterium parvum in acute myelocytic leukemia. _h[electronic resource] |
| 260 |
_bCancer _cJan 1980 |
||
| 300 |
_a280-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCentral Nervous System Diseases _xprevention & control |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aInjections, Spinal |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xtherapy |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPropionibacterium acnes _ximmunology |
| 650 | 0 | 4 | _aRemission, Spontaneous |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aPavlovsky, S | |
| 700 | 1 | _aHidalgo, G | |
| 700 | 1 | _aMuriel, F S | |
| 700 | 1 | _aSuárez, A | |
| 700 | 1 | _aGaray, G | |
| 700 | 1 | _aRusso, C | |
| 700 | 1 | _aSantos, M | |
| 700 | 1 | _aMacchi, A | |
| 700 | 1 | _aLein, J | |
| 773 | 0 |
_tCancer _gvol. 45 _gno. 2 _gp. 280-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19800115)45:2<280::aid-cncr2820450213>3.0.co;2-o _zAvailable from publisher's website |
| 999 |
_c6985502 _d6985502 |
||